Skip to main content
. 2017 Jan 31;16:224–237. doi: 10.1016/j.ebiom.2017.01.028

Fig. 6.

Fig. 6

p53-tg-CPCs engraft in the diabetic heart. (a, b) Areas of myocardial damage (*) in the LV wall; EGFP-positive (green) p53-tg-CPCs are engrafted in the majority of these foci of injury. Cardiomyocytes are labeled by α-sarcomeric actin (α-SA; red).